Donna L. French, PhD, is Vice President, Drug Delivery and Device Development at MedImmune, where she is responsible for the development and commercialization of novel drug delivery systems and drug/device combination product technologies. Prior to MedImmune, Donna was Senior Director of Device Development at Genentech for 8+ years and Executive Director of Drug Delivery Engineering at Amgen Inc for 15 years. For over 20 years, Dr French has been developing and commercializing combination products with a network of technology company partners in the medical device industry.
She has led the technical development and/or commercialization of numerous biopharmaceuticals with delivery devices worldwide, including auto-injectors, pen injectors, needle stick prevention devices, pre-filled syringes, needle-free injectors, patch injectors, intraocular delivery devices and patient aids/tools for drug preparation and administration.
Commercially marketed systems include the Lucentis® intraocular prefilled syringe, NuSpin™ pen injector, SureClick™ disposable auto-injector, UltraSafe® needle guard and SimpleJect™ Auto-Injection System. Prior to her responsibilities in drug/device combination products, she was a scientist researching novel formulations and drug delivery systems for biopharmaceuticals. She received her BS in Pharmacy from the Albany College of Pharmacy in Albany, NY in 1988 and a PhD in Pharmaceutical Sciences from the University of Nebraska in 2004.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)